WallStreetZenWallStreetZen

NASDAQ: XRAY
Dentsply Sirona Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for XRAY

Based on 6 analysts offering 12 month price targets for Dentsply Sirona Inc.
Min Forecast
$35.00-7.06%
Avg Forecast
$43.17+14.62%
Max Forecast
$51.00+35.42%

Should I buy or sell XRAY stock?

Based on 6 analysts offering ratings for Dentsply Sirona Inc.
Buy
Strong Buy
1 analysts 16.67%
Buy
1 analysts 16.67%
Hold
4 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their XRAY stock forecasts and price targets.

XRAY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Barrington Research
Bottom 16%
16
BuyReiterates$51.00+35.42%2023-05-04
Stifel Nicolaus
Bottom 25%
25
HoldMaintains$41.00+8.87%2023-05-04
Morgan Stanley
Top 4%
97
Strong BuyMaintains$47.00+24.80%2023-05-04
Baird
Bottom 47%
47
HoldMaintains$46.00+22.15%2023-05-04
Goldman Sachs
Bottom 14%
14
HoldMaintains$39.00+3.56%2023-03-02
Piper Sandler
Bottom 14%
14
HoldMaintains$35.00-7.06%2023-02-06

1 of 1

Forecast return on equity

Is XRAY forecast to generate an efficient return?
Company
N/A
Industry
0.51%
Market
71.27%

Forecast return on assets

Is XRAY forecast to generate an efficient return on assets?
Company
N/A
Industry
0.22%

XRAY revenue growth forecast

How is XRAY forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
5.9%
Industry
6.6%
Market
8.44%
XRAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XRAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XRAY vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
XRAY$37.66$43.17+14.62%Buy
NVCR$74.90$88.80+18.56%Buy
STVN$27.54$31.75+15.29%Strong Buy
MASI$165.32$181.67+9.89%Strong Buy
RGEN$167.07$202.43+21.16%Strong Buy
View Top Medical Stocks

Dentsply Sirona Stock Forecast FAQ

Is Dentsply Sirona Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: XRAY) stock is to Buy XRAY stock.

Out of 6 analysts, 1 (16.67%) are recommending XRAY as a Strong Buy, 1 (16.67%) are recommending XRAY as a Buy, 4 (66.67%) are recommending XRAY as a Hold, 0 (0%) are recommending XRAY as a Sell, and 0 (0%) are recommending XRAY as a Strong Sell.

If you're new to stock investing, here's how to buy Dentsply Sirona stock.

What is XRAY's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: XRAY) forecast ROE is N/A, which is considered weak.

What is XRAY's Price Target?

According to 6 Wall Street analysts that have issued a 1 year XRAY price target, the average XRAY price target is $43.17, with the highest XRAY stock price forecast at $51.00 and the lowest XRAY stock price forecast at $35.00.

On average, Wall Street analysts predict that Dentsply Sirona's share price could reach $43.17 by May 4, 2024. The average Dentsply Sirona stock price prediction forecasts a potential upside of 14.62% from the current XRAY share price of $37.66.

What is XRAY's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: XRAY) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 0.22%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.